Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD (NCT05572632)
Community-based Pulmonary Rehabilitation (COPD Wellness) and Social Navigation (Health Advocates) to Improve Outcomes in Vulnerable Patients With COPD
🩺 Plain-English Summary (8th-Grade Level)
Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, implementation of this resource-intensive program in real-life settings, and in particular, for underserved communities, has proven to be challenging. Safety-net centers that serve primarily under-insured populations lack financial resources to provide pulmonary rehabilitation. The 10-week COPD Wellness and Plus+ Program directly addresses this gap, and yet, programs like these do not automatically lead to improved outcomes, which leads to the implementation of a Health Advocates program to address participant's social needs and barriers to healthcare.
Who can join: Review the eligibility criteria below.
Location: Zuckerberg San Francisco General (ZSFG) Hospital — San Francisco, California
Age range: 40 Years to 90 Years
🧪 Interventions in This Study
- COPD Wellness (BEHAVIORAL)
- COPD Wellness Plus+ (BEHAVIORAL)
- Usual Care (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Zuckerberg San Francisco General (ZSFG) Hospital — San Francisco, California
- Maxine Hall Health Center (MHHC) — San Francisco, California
- Southeast Health Center (SEHC) — San Francisco, California
📞 Contact the Study Coordinator
Phone: (628) 206-8314
Email: neeta.thakur@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in COPD (Chronic Obstructive Pulmonary Disease)
- Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD — Edmonton, Alberta
- Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD — Omaha, Nebraska
- Development And Evaluation of An Adaptive Web-Based Intervention for COPD — Aurora, Colorado
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia — Durham, North Carolina
- COPD Exacerbation Follow Up — Park Ridge, Illinois
Explore by condition: All COPD (Chronic Obstructive Pulmonary Disease) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.